Recommendation System
Reviewed and published by trentmaziarz, July 9, 2026. Discovered and drafted by our automated research pipeline.
Boston Scientific integrated Coveo's AI-search platform into its B2B e-commerce site to deliver personalized search results, relevance tuning, and behavior-based product recommendations for healthcare facility buyers and sales representatives. The integration has been underway for approximately four years.
Details
Boston Scientific integrated Coveo's AI platform into its SAP Commerce Cloud stack, enabling the e-commerce site to analyze user behavior and past purchase data to surface relevant products, rank search results by predicted relevance, and recommend products to buyers. The company also introduced an 'intent box' — a unified search and chat interface — to reduce friction in product discovery. Boston Scientific has reported that the AI search improvements reduced inbound customer service calls related to product findability and order tracking.
Products affected
Boston Scientific E-Commerce Platform
Sources & Evidence
Cite this record
Trace Foundation. (2026). Boston Scientific: Boston Scientific integrated Coveo's AI-search platform into its B2B e-commerce site to deliver personalized search results, relevance tuning, and behavior-based product recommendations for healthcare facility buyers and sales representatives. The integration has been underway for approximately four years (data as of 2026-07-09) [Data set record]. AI Trace. https://www.aitrace.org/r/practice/5bc105d1-0e9a-4633-b14d-125b2ba5d807. Accessed October 7, 2026.
- Stable link
- https://www.aitrace.org/r/practice/5bc105d1-0e9a-4633-b14d-125b2ba5d807
- Data as of
- July 9, 2026
- Last verified
- August 4, 2026
Other practices by Boston Scientific
Data AnalysisBoston Scientific deployed the AVVIGO+ Multi-Modality Guidance System, which includes an AI software feature called Automated Lesion Assessment that automatically identifies and measures coronary artery blockages during heart procedures. The system received FDA clearance in September 2023.Data AnalysisBoston Scientific deployed BeatLogic, a deep-learning algorithm that automatically analyzes ECG data from cardiac monitoring devices to detect and classify 34 distinct arrhythmias. The system processes over 3 billion heartbeats daily across patients in the United States and sends critical alerts to physicians.Data AnalysisBoston Scientific deployed the LUX-Dx II+ Insertable Cardiac Monitor, which uses an enhanced dual-stage algorithm to automatically detect and verify potential arrhythmias in patients before sending alerts to clinicians. The device is implanted under the skin for long-term continuous heart monitoring.
Have evidence about Boston Scientific's AI practices? Submit a report.
Report a Sighting →